To assess NAPRT and NAMPT expression in tumors, we studied a set of cell lines, which included renal, thyroid, cervix, lung, gastric and colorectal carcinomas, uveal melanoma, and leukemia, by RT-PCR and western blot (Figure 1B and 1C). The gene discussed is NAPRT; the disease is colorectal carcinoma.